Natus Medical was founded in 1989 and is headquartered in Pleasanton, US
Natus Medical Office Locations
Natus Medical has offices in Pleasanton, Chicago, Louisville, Middleton and in 76 other locations
Pleasanton, US (HQ)
120 6701 Koll Center Pkwy
Natus Medical Data and Metrics
Natus Medical Financial Metrics
Natus Medical's revenue was reported to be $381.9 m in FY, 2016 which is a 2% increase from the previous period.
$, USD
Revenue (FY, 2016) | 381.9 m |
Revenue growth (FY, 2015 - FY, 2016), % | 2% |
Gross profit (FY, 2016) | 237.3 m |
Gross profit margin (FY, 2016), % | 62% |
Net income (FY, 2016) | 42.6 m |
EBIT (FY, 2016) | 55.3 m |
Market capitalization (23-Jun-2017) | 1.2 b |
Closing share price (23-Jun-2017) | 36.3 |
Cash (31-Dec-2016) | 213.6 m |
Natus Medical's current market capitalization is $1.2 b.
| $, USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Revenue | 344.1 m | 355.8 m | 375.9 m | 381.9 m |
Revenue growth, % | 3% | 6% | 2% | |
Cost of goods sold | 142.1 m | 145.5 m | 144.6 m | |
Gross profit | 202 m | 214.4 m | 230.4 m | 237.3 m |
Gross profit Margin, % | 59% | 60% | 61% | 62% |
Operating expense total | 167.8 m | 168.5 m | 174.1 m | 179.7 m |
EBIT | 34.3 m | 45.9 m | 53.5 m | 55.3 m |
EBIT margin, % | 10% | 13% | 14% | 14% |
Net Income | 22.9 m | 32.5 m | 37.9 m | 42.6 m |
| $, USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Cash | 56.1 m | 66.6 m | 82.5 m | 213.6 m |
Inventories | 37.7 m | 40.1 m | 48.6 m | 49.6 m |
Current Assets | 196.8 m | 217.8 m | 241.4 m | 405.8 m |
PP&E | 23.3 m | 17.9 m | 17 m | 17.3 m |
Goodwill | 97.2 m | 96.3 m | 107.5 m | 113.1 m |
Total Assets | 426.4 m | 434.8 m | 479.5 m | 649 m |
Accounts Payable | 29.8 m | 21.4 m | 23.7 m | 18.7 m |
Total Debt | 38 m | 38 m | ||
Current Liabilities | 80.1 m | 69.1 m | 77.1 m | 79.9 m |
Retained Earnings | 34.5 m | 68.9 m | 106.8 m | 149.4 m |
Total Equity | 306.3 m | 352.7 m | 390.7 m | 417.4 m |
Debt to Equity Ratio | 0.1 x | 0.1 x | ||
Debt to Assets Ratio | 0.1 x | 0.1 x | ||
Financial Leverage | 1.4 x | 1.2 x | 1.2 x | 1.6 x |
| $, USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Net Income | 22.9 m | 32.5 m | 37.9 m | 42.6 m |
Depreciation and Amortization | 12.8 m | 11.8 m | 16 m | 16.9 m |
Accounts Receivable | 9.4 m | (2.4 m) | (15 m) | 19.7 m |
Inventories | (2.3 m) | (2 m) | (12 m) | (7.7 m) |
Accounts Payable | (1.4 m) | (7.6 m) | 3.3 m | (5 m) |
Cash From Operating Activities | 36.8 m | 42.1 m | 36.9 m | 72.7 m |
Purchases of PP&E | (1.8 m) | (4.2 m) | (4.1 m) | (3.2 m) |
Cash From Investing Activities | (22.3 m) | (10.6 m) | (19.5 m) | (53.3 m) |
Cash From Financing Activities | 17.2 m | (20.9 m) | 832 k | 118.4 m |
Interest Paid | 1.3 m | 434 k | 41 k | |
Income Taxes Paid | 12.9 m | 5.7 m | 10.2 m | 16.3 m |
| $, USD | Y, 2016 |
|---|---|
Revenue/Employee | 357.9 k |
Financial Leverage | 1.6 x |
